ClinicalTrials.gov
ClinicalTrials.gov Menu

Lipitor In The Prevention Of Stroke, For Patients Who Have Had A Previous Stroke (SPARCL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00147602
Recruitment Status : Completed
First Posted : September 7, 2005
Last Update Posted : April 22, 2015
Sponsor:
Information provided by:
Pfizer

September 6, 2005
September 7, 2005
April 22, 2015
November 1998
Not Provided
Time to occurrence of fatal or non-fatal stroke
Same as current
Complete list of historical versions of study NCT00147602 on ClinicalTrials.gov Archive Site
  • Time to occurrence of an acute coronary event, consisting of cardiac death, nonfatal myocardial infarction, resuscitated cardiac arrest or unstable angina.
  • Time to occurrence of a cerebrovascular event, defined as fatal or nonfatal stroke or TIA.
  • a.Time to occurrence of an acute coronary event, consisting of cardiac death, nonfatal myocardial infarction, resuscitated cardiac arrest or unstable angina.
  • b. Time to occurrence of a cerebrovascular event, defined as fatal or nonfatal stroke or TIA.
Not Provided
Not Provided
 
Lipitor In The Prevention Of Stroke, For Patients Who Have Had A Previous Stroke
A Double-Blind, Randomized, Placebo- Controlled Study Of Atorvastatin As Prevention Of Cerebrovascular Events In Patients With A Previous Transient Ischemic Attack (TIA) Or Stroke
To determine whether Lipitor reduces stroke, compared to placebo in patients who have had a previous stroke or transient ischemic attack.
Not Provided
Interventional
Phase 4
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double
Primary Purpose: Treatment
Cardiovascular Disease
Drug: atorvastatin
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
4732
Same as current
November 2005
Not Provided

Inclusion Criteria:

  • Previous stroke or TIA

Exclusion Criteria:

  • coronary heart disease
Sexes Eligible for Study: All
18 Years and older   (Adult, Older Adult)
No
Contact information is only displayed when the study is recruiting subjects
Australia,   Austria,   Belgium,   Brazil,   Chile,   Czech Republic,   Denmark,   Finland,   France,   Germany,   Greece,   Israel,   Italy,   Mexico,   Netherlands,   New Zealand,   Poland,   Portugal,   Slovakia,   South Africa,   Spain,   Sweden,   Switzerland,   United Kingdom,   Venezuela
 
 
NCT00147602
0981-342
A2581138
Not Provided
Not Provided
Not Provided
Not Provided
Pfizer
Not Provided
Study Director: Pfizer CT.gov Call Center Pfizer
Pfizer
April 2015

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP